Homocysteine induces oxidative stress in young adult central retinal vein occlusion

British Journal of Ophthalmology

Volumn 96, Issue 8, 2012, Pages 1122-1126

  Devi, Subramaniam Rajesh Bharathi ^a   Suganeswari, Ganesan ^a   Sharma, Tarun ^a   Thennarasu, Maruthamuthu ^b   Angayarkanni, Narayanasamy ^a  

^a MEDICAL RESEARCH FOUNDATION   (India)

^b VISION RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL;

ADULT; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; ANIMAL CELL; ARTICLE; BLOOD ANALYSIS; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; COW; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; HUMAN; IN VITRO STUDY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR;

ADULT; ANIMALS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CATTLE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; HUMANS; MALE; OXIDATIVE STRESS; PILOT PROJECTS; REACTIVE OXYGEN SPECIES; RETINAL VEIN OCCLUSION; RISK FACTORS; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; YOUNG ADULT;

EID: 84864855333     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-301370     Document Type: Article

References (44)

1. Mohamed Q, McIntosh RL, Saw SM, et al. Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2007;114:507-19; 524.
2. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002;288:2015-22.
3. Narayanasamy A, Subramaniam B, Karunakaran C, et al. Hyperhomocysteinemia and low methionine stress are risk factors for central retinal venous occlusion in an Indian population. Invest Ophthalmol Vis Sci 2007;48:1441-6. (Pubitemid 351261323)
4. Handy DE, Zhang Y, Loscalzo J. Homocysteine down-regulates cellular glutathione peroxidase (GPx1) by decreasing translation. J Biol Chem 2005;280:15518-25. (Pubitemid 40616667)
5. Kolling J, Scherer EB, da Cunha AA, et al. Homocysteine induces oxidative-nitrative stress in heart of rats: prevention by folic acid. Cardiovasc Toxicol 2011;11:67-73.
6. Frank J, Beck SC, Flaccus A, et al. No evidence for prooxidative effects of homocysteine in vascular endothelial cells. Eur J Nutr 2007;46:286-92. (Pubitemid 47134746)
7. Perna AF, Ingrosso D, De Santo NG. Homocysteine and oxidative stress. Amino Acids 2003;25:409-17. (Pubitemid 38041275)
8. Coral K, Raman R, Rathi S, et al. Plasma homocysteine and total thiol content in patients with exudative age-related macular degeneration. Eye (Lond) 2006;20:203-7.
9. Koracevic D, Koracevic G, Djordjevic V, et al. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 2001;54:356-61. (Pubitemid 32458132)
10. Devasagayam TP, Tarachand U. Decreased lipid peroxidation in the rat kidney during gestation. Biochem Biophys Res Commun 1987;145:134-8. (Pubitemid 17088415)
11. Rotruck JT, Pope AL, Ganther HE, et al. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973;179:588-90.
12. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247:3170-5.
13. Calugaru D. Etiology of central retinal vein occlusion. Oftalmologia 2011;55:12-26.
14. Vine AK. Hyperhomocysteinemia: a risk factor for central retinal vein occlusion. Am J Ophthalmol 2000;129:640-4. (Pubitemid 30323731)
15. McGimpsey SJ, Woodside JV, Cardwell C, et al. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis. Ophthalmology 2009;116:1778-87.e1.
16. Cahill MT, Stinnett SS, Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 2003;136:1136-50. (Pubitemid 37485782)
17. Pinna A, Carru C, Zinellu A, et al. Plasma homocysteine and cysteine levels in retinal vein occlusion. Invest Ophthalmol Vis Sci 2006;47:4067-71. (Pubitemid 46044326)
18. Di Crecchio L, Parodi MB, Sanguinetti G, et al. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion. Ophthalmology 2004;111:940-5. (Pubitemid 38586688)
19. Moghimi S, Najmi Z, Faghihi H, et al. Hyperhomocysteinemia and central retinal vein occlusion in Iranian population. Int Ophthalmol 2008;28:23-8. (Pubitemid 351308681)
20. Gao W, Wang YS, Zhang P, et al. Hyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case-control study in a Chinese population. Graefes Arch Clin Exp Ophthalmol 2006;244:1246-9. (Pubitemid 44463461)
21. Lattanzio R, Sampietro F, Ramoni A, et al. Moderate hyperhomocysteinemia and early-onset central retinal vein occlusion. Retina 2006;26:65-70. (Pubitemid 44391754)
22. Sodi A, Giambene B, Marcucci R, et al. Atherosclerotic and thrombophilic risk factors in patients with recurrent central retinal vein occlusion. Eur J Ophthalmol 2008;18:233-8. (Pubitemid 351692183)
23. Sofi F, Marcucci R, Bolli P, et al. Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. Atherosclerosis 2008;198:223-7. (Pubitemid 351410544)
24. Bao XM, Wu CF, Lu GP. Atorvastatin inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells. Acta Pharmacol Sin 2010;31:476-84.
25. Topal G, Brunet A, Millanvoye E, et al. Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin. Free Radic Biol Med 2004;36:1532-41. (Pubitemid 38746561)
26. Wotherspoon F, Laight DW, Browne DL, et al. Plasma homocysteine, oxidative stress and endothelial function in patients with type 1 diabetes mellitus and microalbuminuria. Diabet Med 2006;23:1350-6. (Pubitemid 44787800)
27. Zhang D, Jiang X, Fang P, et al. Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice. Circulation 2009;120:1893-902.
28. Lee SJ, Kang MH, Min H. Folic acid supplementation reduces oxidative stress and hepatic toxicity in rats treated chronically with ethanol. Nutr Res Pract 2011;5:520-6.
29. Wang X, Cui L, Joseph J, et al. Homocysteine induces cardiomyocyte dysfunction and apoptosis through p38 MAPK-mediated increase in oxidant stress. J Mol Cell Cardiol 2011;53:753-60.
30. Szamosi T, Roth E, Szamosi T Jr, et al. Hyperhomocysteinemia, enzyme polymorphism and thiobarbituric Acid reactive system in children with high coronary risk family history. J Am Coll Nutr 2004;23:386-90.
31. Aghamohammadi V, Gargari BP, Aliasgharzadeh A. Effect of folic acid supplementation on homocysteine, serum total antioxidant capacity, and malondialdehyde in patients with type 2 diabetes mellitus. J Am Coll Nutr 2011;30:210-15.
32. Dietrich-Muszalska A, Malinowska J, Olas B, et al. The oxidative stress may be induced by the elevated homocysteine in schizophrenic patients. Neurochem Res 2012;37:1057-62.
33. Angayarkanni N, Barathi S, Seethalakshmi T, et al. Serum PON1 arylesterase activity in relation to hyperhomocysteinaemia and oxidative stress in young adult central retinal venous occlusion patients. Eye (Lond) 2008;22:969-74.
34. Sipkens JA, Hahn N, van den Brand CS, et al. Homocysteine-induced apoptosis in endothelial cells coincides with nuclear NOX2 and peri-nuclear NOX4 activity. Cell Biochem Biophys 2011. doi:10.1007/s12013-011-9297-y
35. Zhu J, Xie R, Piao X, et al. Homocysteine enhances clot-promoting activity of endothelial cells via phosphatidylserine externalization and microparticles formation. Amino Acids 2011. doi:10.1007/s00726-011-1196-4
36. Erol A, Cinar MG, Can C, et al. Effect of homocysteine on nitric oxide production in coronary microvascular endothelial cells. Endothelium 2007;14:157-61. (Pubitemid 46995443)
37. Barathi S, Angayarkanni N, Pasupathi A, et al. Homocysteinethiolactone and paraoxonase: novel markers of diabetic retinopathy. Diabetes care 2010;33:2031-7.
38. Lee I, Lee H, Kim JM, et al. Short-term hyperhomocysteinemia-induced oxidative stress activates retinal glial cells and increases vascular endothelial growth factor expression in rat retina. Biosci Biotech Biochem 2007;71:1203-10. (Pubitemid 47164249)
39. McCully KS. Chemical pathology of homocysteine. IV. Excitotoxicity, oxidative stress, endothelial dysfunction, and inflammation. Ann Clin Lab Sci 2009;39:219-32.
40. Outinen PA, Sood SK, Liaw PC, et al. Characterization of the stress-inducing effects of homocysteine. Biochem J 1998;332:213-21. (Pubitemid 28239337)
41. Kawashima A, Madarame T, Koike H, et al. Four week supplementation with mixed fruit and vegetable juice concentrates increased protective serum antioxidants and folate and decreased plasma homocysteine in Japanese subjects. Asia Pac J Clin Nutr 2007;16:411-21. (Pubitemid 47463617)
42. Stiefel P, Arguelles S, Garcia S, et al. Effects of short-term supplementation with folic acid on different oxidative stress parameters in patients with hypertension. Biochim Biophysica Acta 2005;1726:152-9.
43. Debreceni B, Debreceni L. Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases? Cardiovasc Ther 2012;30:227-33.
44. Dhonukshe-Rutten RA, de Vries JH, de Bree A, et al. Dietary intake and status of folate and vitamin B12 and their association with homocysteine and cardiovascular disease in European populations. Eur J Clin Nutr 2009;63:18-30.